Medtronic Wins FDA Approval for MyCareLink Smart Monitor
Medical device giant Medtronic has received FDA approval for its MyCareLink Smart Monitor, an app-based remote monitoring system for patients with implantable pacemakers.
The system — now commercially available — allows patients to transmit data from their Medtronic pacemakers to their physicians with a smartphone or tablet. Physicians can then interpret the data to make treatment decisions.
The smartphone app is available through both the Apple and Android platforms.
Patients also can use the system to confirm the date of their most recent transmission of pacemaker information, create a personalized profile on the MyCareLink Connect website to manage their pacemaker information and data transmissions, as well as receive email or text reminders, confirmations and notifications of their data transmissions. — Michael Cipriano